roche holding ag-genusschein
(ROG:SIX SWISS EXCHANGE AG)
Richard H. Scheller Ph.D.
|Age||Total Calculated Compensation||This person is connected to 23 board members in 3 different organizations across 8 different industries.|
See Board Relationships
Dr. Richard H. Scheller, Ph.D., has been the Chief Science Officer and Head of Therapeutics at 23andMe, Inc. since April 2015. Mr. Scheller is responsible for translating genetic information into the discovery and development of new therapies for both common and rare diseases. He serves as a Science Partner at The Column Group LLC. He serves as an Adjunct Professor of the Department of Biochemistry and Biophysics, School of Medicine at University of California, San Francisco. ...
Konzern-HauptsitzPhone: 41 61 688 11 11
Basel, Basel-Stadt 4070
Fax: 41 61 691 93 91
Board Members Memberships*
Bachelor's Degree 1975
University of Wisconsin - Madison
California Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|